Rocuronium Bromide Injection
Product Images NDC 67457-228

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 67457-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Time To 80% Or Greater Block Vs. Initial Dose Of Rocuronium Bromide Injection By Age Group (median, 25th And 75th Percentile, And Individual Values) (E7d54155 493b 4cf1 B716 29605150b9e6 02)

Figure 1: Time To 80% Or Greater Block Vs. Initial Dose Of Rocuronium Bromide Injection By Age Group (median, 25th And 75th Percentile, And Individual Values) (E7d54155 493b 4cf1 B716 29605150b9e6 02)
Box plot chart showing the distribution of a measured variable in minutes across different mg/kg dosages of rocuronium bromide for three age groups: 18-64 years, 65 years and older, and 1-12 years. The x-axis represents dosage in mg/kg, and the y-axis represents time in minutes, with data points indicating variability within each group and dosage.*
FDA Label Image

Figure 2: Duration Of Clinical Effect Vs. Initial Dose Of Rocuronium Bromide Injection By Age Group (median, 25th And 75th Percentile, And Individual Values) (E7d54155 493b 4cf1 B716 29605150b9e6 03)

Figure 2: Duration Of Clinical Effect Vs. Initial Dose Of Rocuronium Bromide Injection By Age Group (median, 25th And 75th Percentile, And Individual Values) (E7d54155 493b 4cf1 B716 29605150b9e6 03)
A box plot graph depicting the distribution of minutes on the y-axis across different age groups and mg/kg dosages on the x-axis for Rocuronium Bromide injection. Age groups include 18–64 years, 65 years and older, 3 months to 1 year, and 1 to 12 years, with corresponding dosage levels indicated below each group.*
FDA Label Image

Figure 3: Duration Of Clinical Effect Vs. Number Of Rocuronium Bromide Injection Maintenance Doses, By Dose (E7d54155 493b 4cf1 B716 29605150b9e6 04)

Figure 3: Duration Of Clinical Effect Vs. Number Of Rocuronium Bromide Injection Maintenance Doses, By Dose (E7d54155 493b 4cf1 B716 29605150b9e6 04)
A line graph showing the relationship between dose number (x-axis) and time in minutes (y-axis) for Rocuronium Bromide injection. Two dosage groups are plotted, 0.1 mg/kg (N=29) and 0.15 mg/kg (N=13), with time increasing over consecutive doses for both groups.*
FDA Label Image

Rocuronium Bromide Injection 50 mg/5 mL Carton Label (Image 01)

Rocuronium Bromide Injection 50 mg/5 mL Carton Label (Image 01)
Packaging label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) by Mylan Institutional LLC. The label indicates it is a paralyzing agent for intravenous use only, supplied as 10 multi-dose vials of 5 mL each. Storage instructions, warnings, and barcode are included on the label.*
FDA Label Image

Rocuronium Bromide Structural Formula (Image 04)

Rocuronium Bromide Structural Formula (Image 04)
Chemical structure diagram of rocuronium bromide showing its molecular components including rings, functional groups, and charged nitrogen. The image depicts the structural formula with carbon, hydrogen, oxygen atoms, and bromide ion indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.